India’s Sun Pharma to buy US-listed Organon in $11.75 billion deal

April 26 (Reuters) – Sun Pharmaceutical Industries said on Sunday it will buy Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.75 billion including debt, in one of India’s …